Literature DB >> 19835967

Rare extraintestinal infection caused by toxin-producing Clostridium difficile.

Edit Urbán1, Gabriella Terhes, Attila Markotics, József Sóki, Elizabeth Nagy.   

Abstract

Toxigenic Clostridium difficile is a well known cause of antibiotic-associated diarrhea mainly among hospitalized patients, at the same time we have little information about extraintestinal infections caused by this bacterium. We report here on rare extraintestinal infection caused by toxigenic C. difficile: 31-year-old male, accident victim was admitted to the hospital because of polytrauma. Microbiological examination of the pus revealed a toxin-producing C. difficile as an etiologic factor of this infection. Empiric antibiotic treatment with cefuroxime had been administered right after the positive microbiological result. On the basis of antibiotic susceptibility testing, the isolated strain was susceptible to most antimicrobials, except from cefoxitin, thus cefuroxime was changed to imipenem. 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19835967     DOI: 10.1016/j.anaerobe.2009.10.004

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


  3 in total

1.  Clostridium difficile ribotype 078 cultured from post-surgical non-healing wound in a patient carrying ribotype 014 in the intestinal tract.

Authors:  Otakar Nyc; Marcela Krutova; Jiri Kriz; Jana Matejkova; Eliska Bebrova; Veronika Hysperska; Ed J Kuijper
Journal:  Folia Microbiol (Praha)       Date:  2015-05-03       Impact factor: 2.099

2.  Clostridium difficile infection: An overview of the disease and its pathogenesis, epidemiology and interventions.

Authors:  V K Viswanathan; M J Mallozzi; Gayatri Vedantam
Journal:  Gut Microbes       Date:  2010-06-16

3.  Extraintestinal Clostridioides difficile Infections: Epidemiology in a University Hospital in Hungary and Review of the Literature.

Authors:  Edit Urbán; Gabriella Terhes; Márió Gajdács
Journal:  Antibiotics (Basel)       Date:  2020-01-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.